Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
2018; Nature Portfolio; Volume: 24; Issue: 11 Linguagem: Inglês
10.1038/s41591-018-0198-0
ISSN1546-170X
AutoresChristian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi, Karolina Sikorska, B. van de Wiel, Pia Kvistborg, Oscar Krijgsman, Marlous van den Braber, Daisy Philips, Annegien Broeks, Johannes V. van Thienen, Henk Mallo, S. Adriaansz, Sylvia ter Meulen, Loes M. Pronk, Lindsay G. Grijpink-Ongering, Annemarie Bruining, Rachel M. Gittelman, Sarah Warren, Harm van Tinteren, Daniel S. Peeper, John B.A.G. Haanen, Alexander C.J. van Akkooi, Ton N. Schumacher,
Tópico(s)Immunotherapy and Immune Responses
Referência(s)